Yosef Tsegaye Dabi (Yosef T Dabi)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Top Venues

Immunity, inflammation and disease

Journal of inflammation research

Diabetes, metabolic syndrome and obesity : targets and therapy

Biologics : targets & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yosef Tsegaye Dabi, Abayomi O Ajagbe, Sisay Teka Degechisa
Toll-like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential. Immunity, inflammation and disease 11 (4) (2023)
Yosef Tsegaye Dabi, Abayomi O Ajagbe, Sisay Teka Degechisa
Toll-like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential. Immunity, inflammation and disease 11 (4) (2023)
Yosef Tsegaye Dabi, Abayomi O Ajagbe, Sisay Teka Degechisa
Toll-like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential. Immunity, inflammation and disease 11 (4) (2023)
Sisay Teka Degechisa, Yosef Tsegaye Dabi
Leptin Deficiency May Influence the Divergence of Cell-Mediated Immunity Between Lepromatous and Tuberculoid Leprosy Patients. Journal of inflammation research 15 (2022)
Yosef Tsegaye Dabi, Sisay Teka Degechisa
Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Sisay T Degechisa, Yosef Tsegaye Dabi, Solomon T Gizaw
The mitochondrial associated endoplasmic reticulum membranes: A platform for the pathogenesis of inflammation-mediated metabolic diseases. Immunity, inflammation and disease 10 (7) (2022)
Yosef Tsegaye Dabi, Henok Andualem, Sisay Teka Degechisa, Solomon Tebeje Gizaw
Targeting Metabolic Reprogramming of T-Cells for Enhanced Anti-Tumor Response. Biologics : targets & therapy 16 (2022)
Sisay Teka Degechisa, Yosef Tsegaye Dabi
Leptin Deficiency May Influence the Divergence of Cell-Mediated Immunity Between Lepromatous and Tuberculoid Leprosy Patients. Journal of inflammation research 15 (2022)